Apoptotic Processes in Megakaryocytes and Platelets
It is becoming increasingly clear that most mammalian cells are capable of undergoing apoptosis and that, within particular lineages, specific apoptotic pathways have evolved to regulate survival and turnover. The role of apoptosis in the megakaryocyte lineage is an intriguing one. Various insults, such as chemotherapeutics, autoantibodies, and human immunodeficiency virus (HIV), have been suggested to induce the apoptotic death of megakaryocytes and/or their progenitors. Conversely, apoptotic processes have been implicated in megakaryocyte development and platelet production. Platelets also contain functional apoptotic pathways, which circumscribe their survival. It has even been suggested that platelet activation responses involve components of the apoptotic machinery, highlighting a potential role for apoptotic processes in hemostasis and thrombosis. This review discusses the current state of knowledge about how apoptosis and apoptotic proteins contribute to the generation and function of megakaryocytes and platelets.
aMolecular Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
bDepartment of Medical Biology, The University of Melbourne, Victoria, Australia
Address correspondence to Benjamin Kile, PhD, Molecular Medicine Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville 3052, Victoria, Australia
This work was supported by the Australian National Health and Medical Research Council (Project Grants No. 516725 and 575535), the Sylvia and Charles Viertel Charitable Foundation (Fellowship to B.T.K.), and the Leukaemia Foundation of Australia (Scholarship to M.J.W.).